Drugs by condition
Drugs approved for chronic constipation
Last checked: Nov 19, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations
Brand-name drugs approved
8
Still marketed, NDA or BLA
Drug classes
3
Novel drugs
7
New molecular entities and new biologics
In development
0
Investigational drugs in Phase 2 or 3
Newest approvals
The most recently first-approved brand-name drugs for chronic constipation.
All approved drugs for chronic constipation, by class
Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 18 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.
Guanylate Cyclase-C Agonist (2)
Chloride Channel Activator (1)
- Amitiza Lubiprostone · Sucampo Pharma LLC · 2006
Class not listed in FDA's data (5)
Drugs in development for chronic constipation
Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.
No investigational drugs in Phase 2 or 3 trials list this condition.
More on chronic constipation: recruiting trials · published research
Related in gastroenterology and liver: MASH (fatty liver disease) · Primary biliary cholangitis · Acid reflux (GERD) · Irritable bowel syndrome · Nausea and vomiting · Eosinophilic esophagitis
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.